| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/16/2023 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 16.5k | $1.82 | $30k | | 05/16/2023 |
| 04/01/2023 | Replimune Group, Inc. | REPL | Grant | Stock Option (right to buy) | 25.2k | $17.66 | $445k | | 04/01/2023 |
| 06/10/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 15k | $2.14 | $32.1k | | 06/10/2022 |
| 04/01/2022 | Replimune Group, Inc. | REPL | Grant | Stock Option (right to buy) | 16.5k | $18.26 | $301.3k | | 04/01/2022 |
| 06/18/2021 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 15k | $12.55 | $188.2k | | 06/18/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 20k | $4.14 | $82.8k | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 15k | $6.09 | $91.4k | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 10k | $17.27 | $172.7k | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 10k | $29.80 | $298k | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 25k | $37.99 | $949.8k | | 04/16/2021 |
| 04/01/2021 | Replimune Group, Inc. | REPL | Grant | Stock Option (right to buy) | 16.5k | $31.58 | $521.1k | | 04/01/2021 |
| 01/19/2021 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 29.8k | $27.45 | $819.2k | | 01/19/2021 |
| 12/07/2020 | Replimune Group, Inc. | REPL | Exercise | Stock Option (right to buy) | 40k | $1.75 | $70k | | 12/07/2020 |
| 12/07/2020 | Replimune Group, Inc. | REPL | Sale | Common Stock | 24.7k | $45.09 | $1.1M | | 12/07/2020 |
| 12/07/2020 | Replimune Group, Inc. | REPL | Sale | Common Stock | 13.5k | $46.22 | $625k | | 12/07/2020 |
| 12/07/2020 | Replimune Group, Inc. | REPL | Sale | Common Stock | 1.8k | $47.04 | $84.8k | | 12/07/2020 |
| 05/14/2020 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 20k | $4.14 | $82.8k | | 05/14/2020 |
| 04/01/2020 | Replimune Group, Inc. | REPL | Grant | Stock Option (right to buy) | 16.5k | $9.78 | $161.4k | | 04/01/2020 |
| 06/10/2019 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 15k | $6.09 | $91.4k | | 06/10/2019 |
| 04/01/2019 | Replimune Group, Inc. | REPL | Grant | Stock Option (right to buy) | 13.5k | $15.50 | $209.2k | | 04/01/2019 |
| 07/24/2018 | Replimune Group, Inc. | REPL | Grant | Stock Option (right to buy) | 13.5k | $15.00 | $202.5k | | 07/24/2018 |
| 05/10/2018 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 10k | $17.27 | $172.7k | | 05/10/2018 |
| 05/10/2017 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 10k | $29.80 | $298k | | 05/10/2017 |
| 05/19/2016 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 10k | $42.25 | $422.5k | | 05/19/2016 |